retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Agonism Based Therapies for Obesity Retatrutide—A Game Changer in Obesity

A.NiculasC.VargaA.TileaI

Side effects: Nausea (take with food if occurs) Sulfur smell (normal) Rare: rash, wheezing (discontinue if allergic) Expected timeline: Noticeable improvements in energy, skin quality, and recovery within 2-4 weeks

Big Pharmas Role: Speculation about pharmaceutical companies influencing the FDAs decision highlights concerns about competition and access to new treatments

Tirzepatide already covers GLP-1 (so semaglutide adds redundancy)

The pathophysiology of COPD is characterized by an imbalance between antioxidants and oxidants, known as oxidative stress, which is a critical factor in this inflammatory lung disease

In addition, the drugs can cause significant and dangerous side effects